在人类细胞中,抗CRISPR介导的CRISPR-Cas9的持续定向进化
Andrew L Sabol1,2, Amanuella A Mengiste1,2, Vedagopuram Sreekanth1,3
1Contributed equally to this work.
bioRxiv : the preprint server for biology
|December 19, 2025
概括
研究人员开发了CRISPR-MACE,这是一种用于直接在人体细胞中进行CRISPR-Cas系统持续定向进化的新方法,可以创建改进的基因组编辑工具.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 基因编辑 基因编辑
背景情况:
- 对于研究和治疗来说,CRISPR-Cas系统工程至关重要.
- 当前的优化方法往往无法复制哺乳动物细胞环境.
- 在人类细胞中缺乏持续指导进化的强有力的策略.
研究的目的:
- 引入CRISPR-MACE (哺乳动物细胞启用腺病毒辅助的持续进化) 用于人类细胞中CRISPR-Cas系统的持续定向进化.
- 产生新的Streptococcus pyogenes Cas9 (SpCas9) 变种,具有改变的DNA结合和增强的抑制剂耐药性.
- 建立哺乳动物细胞内CRISPR-Cas系统持续演化的原则.
主要方法:
- 利用基于病毒的连续进化,与基于抗CRISPR的可调性选择集成.
- 在哺乳动物细胞的进化中采用腺病毒辅助的方法.
- 专注于SpCas9变种的定向进化.
主要成果:
- 产生的SpCas9变体具有增加和减少的DNA结合能力.
- 获得了对SpCas9抑制剂AcrIIA4.4的近1000倍增强的耐药性.
- 确定了一种可复制的Cas9守门员突变,使其能够沿着两个功能轴进行适应性进化.
结论:
- 克里斯普-MACE是人类细胞中基因组向剂的基础技术.
- 证明了对改变DNA结合和抑制剂耐药性的SpCas9的进化能力.
- 已确立的原则和合成电路,用于哺乳动物系统中CRISPR-Cas系统的持续演变.
更多相关视频
09:04Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
Published on: September 25, 2019
8.7K
11:37Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution
Published on: February 26, 2019
10.2K
相关概念视频
CRISPR/Cas9 Genome Editing
1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K
CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
Homologous Recombination
62.4K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.4K
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
